476 related articles for article (PubMed ID: 3980997)
21. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
[TBL] [Abstract][Full Text] [Related]
22. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
Schafer R; Nacy CA; Eisenstein TK
J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
[TBL] [Abstract][Full Text] [Related]
23. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
24. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.
Tempone AG; Perez D; Rath S; Vilarinho AL; Mortara RA; de Andrade HF
J Antimicrob Chemother; 2004 Jul; 54(1):60-8. PubMed ID: 15163652
[TBL] [Abstract][Full Text] [Related]
25. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
[TBL] [Abstract][Full Text] [Related]
26. An increased adjuvanticity of liposomes by the inclusion of phosphatidylserine in immunization with surface-coupled liposomal antigen.
Mori M; Nishida M; Maekawa N; Yamamura H; Tanaka Y; Kasai M; Taneichi M; Uchida T
Int Arch Allergy Immunol; 2005 Jan; 136(1):83-9. PubMed ID: 15591816
[TBL] [Abstract][Full Text] [Related]
27. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
28. Ca2+-calmodulin regulates the induction and expression of macrophage cytotoxicity.
Nguyen HK; Cain CA; Tompkins WA
J Biol Response Mod; 1987 Apr; 6(2):154-68. PubMed ID: 3585411
[TBL] [Abstract][Full Text] [Related]
29. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
30. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
31. Modulation of cyclic AMP-dependent protein kinase isozyme expression associated with activation of a macrophage cell line.
Justement LB; Aldrich WA; Wenger GD; O'Dorisio MS; Zwilling BS
J Immunol; 1986 Jan; 136(1):270-7. PubMed ID: 2999244
[TBL] [Abstract][Full Text] [Related]
32. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
33. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line.
Scott P; James S; Sher A
Eur J Immunol; 1985 Jun; 15(6):553-8. PubMed ID: 2988973
[TBL] [Abstract][Full Text] [Related]
34. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
35. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
36. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
37. Effect of lipopolysaccharide on intracellular killing of Leishmania enriettii and correlation with macrophage oxidative metabolism.
Mauël J; Buchmüller-Rouiller Y
Eur J Immunol; 1987 Feb; 17(2):203-8. PubMed ID: 3030768
[TBL] [Abstract][Full Text] [Related]
38. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
Aramaki Y; Murai M; Tsuchiya S
Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
[TBL] [Abstract][Full Text] [Related]
39. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
[TBL] [Abstract][Full Text] [Related]
40. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]